A candidate identification questionnaire for postmenopausal osteoporosis patients switched from daily or weekly bisphosphonate to once-monthly ibandronate: An open, prospective, multicenter study—BONCURE study

1. ¹ Department of PMR, School of Medicine, Hacettepe University, Ankara, Turkey
2. ² Department of PMR, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey
3. ³ Department of PMR, School of Medicine, Uludag University, Bursa, Turkey
4. ⁴ Department of PMR, School of Medicine, Gazi University, Ankara, Turkey
5. ⁵ Department of PMR, School of Medicine, Selcuk University, Konya, Turkey
6. ⁶ Department of PMR, School of Medicine, Ege University, Izmir, Turkey
7. ⁷ Department of PMR, School of Medicine, Pamukkale University, Denizli, Turkey
8. ⁸ Klinicki Bolnicki Centar, Zagreb, Croatia
9. ⁹ Clinical Hospital Centre, Split, Croatia
10. ¹⁰ Clinic of Rheumatology, Clinical Centre, Skopje, Macedonia
11. ¹¹ Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje, Macedonia
12. ¹² Clinic for Orthopaedic Surgery, Clinical Centre Vodnjansk, Skopje, Macedonia
13. ¹³ Institute of Rheumatology, Belgrade, Serbia
14. ¹⁴ Institute of Endocrinology CCS, Belgrade, Serbia
15. ¹⁵ Institut Za Prevenciju, Lecenje I Rehabilitaciju, Niska Banja, Serbia
16. ¹⁶ Clinical Center of Vojvodina, Novi Sad, Serbia
17. ¹⁷ Orthopaedic Department, University Hospital Center “Mother Teresa”, Tirana, Albania
18. ¹⁸ Department of Rheumatology, University Hospital Center “Mother Teresa”, Tirana, Albania
19. ¹⁹ Institute for Nuclear Medicine, Sarajevo, Bosnia and Herzegovina
20. ²⁰ Institute of Physical Medicine & Rehabilitation, Sarajevo, Bosnia and Herzegovina
21. ²¹ University Hospital Center of Tuzla, Tuzla, Bosnia and Herzegovina
22. ²² Clinical Center, Banja Luka, Bosnia and Herzegovina
23. ²³ Department of PMR, School of Medicine, Akdeniz University, Ankara, Turkey